Shigetaka Katow, Ph.D.

Guest Researcher

Centers for Disease Control and Prevention

National Center for Infectious Disease,

Division of Viral and Rickettsial Diseases,

Branch of Enteric and Respiratory Viruses,

Measles Virus Section,

Rubella Virus Laboratory

Address:

CDC/NCID mailstop C-22,

1600 Clifton Road NE, Atlanta GA 30333

TEL:(404) 639-3308

FAX:(404) 639-1516

e-mail:sqk6@cdc.gov

Dr. Katow is a graduate of the University of Tokyo, Faculty of Science, Department of Biology in 1964. He received a Ph.D. from the University of Tokyo in 1989.

He started his career in virology at the National Institute of Health in Tokyo(now the National Institute of Infectious Diseases) in 1969 and reached the required retirement age in 2002 as a laboratory chief of rubella and varicella viruses. During these 33 years in NIID, he received honors including:

-- Visiting Lecturer, the University of Tokyo, Faculty of Medicine, Department of Developmental Medicine, 2000-02.

-- Visiting Lecturer, the Air University, 2000-02.

-- Visiting Scientist, Georgia State University, Faculty of Arts and Science, Department of Biology, 1990-91 and 1998-99.

-- Expert, Japan International Cooperation Agency on the project at the National Institute of Health, Thailand 1984-1989.

-- Advisory Member, World Health Organization on preventing rubella and congenital rubella syndrome (CRS), 2000.

-- Visiting Scientist, Nagasaki University, the Institute of Tropical Medicine, 1992-93.

-- Trustee Member, the Japanese Association of Vaccinology, 2002-05.

-- Secretary General, editorial board of Vaccine Handbook (Editor: Researchers Associate of the National Institute of Health,), 1994-1998, Maruzen Tokyo.

-- Who’s Who in the World, 1998-2004, Marquis Press.

-- Who’s Who in Japan, 2002-04, Fusosha.

Dr. Katow is one of the leading scientists in rubella virus research, who having authored or coauthored over 100 papers. His research interests have focused on mechanism and eradication of CRS, which concretely including (1) rubella virus genome diagnosis: for fetuses during the early stage of pregnancy and for patients with congenital rubella syndrome (CRS) and postnatal infection,(2) development of animal model for CRS,(3)surveillance of rubella and CRS in Japan, (4)molecular epidemiology of rubella in Japan and in the world,(5) planning of a strategy for eradication of rubella and CRS in Japan and in the world, (6) quality control of live rubella vaccines in Japan,(7)quality control of rubella IgM EIA kits and hemagglutination inhibition tests in Japan, and (8) combined strategy of measles and rubella eradication in the world.